Chondrogenic Progenitor Cell Dynamics in Osteoarthritis

Articular cartilage harbours a specialised subset of chondrogenic progenitor cells (CPCs) that contribute to tissue maintenance, repair and pathology in osteoarthritis (OA). Under homeostatic conditions, CPCs reside in the superficial zone and demonstrate migratory and multilineage differentiation capacities, replenishing damaged matrix. In OA, altered inflammatory and mechanical cues disrupt CPC dynamics, leading to heterogeneous sub-populations: some exhibit early replicative senescence and diminished chondrogenic potential, while others retain extended viability but adopt hypertrophic or osteogenic programmes. Crosstalk with subchondral bone, inflammatory cytokines and paracrine signals further modulates CPC fate, influencing cartilage degeneration or attempted repair. Emerging insights into CPC‐derived extracellular vesicles underscore their key role in mediating protective and regenerative signals within the osteoarthritic joint.

Research from Nature Portfolio

Recent foundational studies have defined divergent progenitor subsets within osteoarthritic cartilage distinguished by telomere erosion and senescence markers. One seminal investigation revealed that a subset of CPCs in OA cartilage shows increased senescence‐associated β-galactosidase activity and shorter telomeres yet retains limited multipotency, whereas a second pool of progenitors maintains replicative capacity and robust chondrogenic potential. Complementary molecular characterisation of mesenchymal stem cell-like populations in human OA cartilage identified CD166+ cells enriched in chondrocyte clusters that preferentially express hypertrophic markers such as COL10A1 and RUNX2. This work suggests these CPCs directly contribute to OA phenotypes via dysregulated gene networks involving RUNX2 and NOTCH1, highlighting them as novel targets for therapeutic modulation.

Chondrogenic Progenitor Cell Dynamics in Osteoarthritis publication trend

The graph below shows the total number of articles in chondrogenic progenitor cell dynamics in osteoarthritis across all publications each year (not limited to Nature Index journals).

Technical terms

Chondrogenic progenitor cells (CPCs): A resident population in articular cartilage capable of migrating, self-renewal and differentiation into chondrocytes, osteoblasts or adipocytes.

Extracellular vesicles (EVs): Nano-sized membranous particles secreted by cells that carry proteins, lipids and nucleic acids to modulate recipient cell functions.

Replicative senescence: A state of permanent cell cycle arrest associated with telomere shortening and senescence-associated markers, impairing tissue repair.

Hypertrophy: The process by which chondroprogenitors or chondrocytes enlarge and express markers of endochondral ossification, often contributing to pathological cartilage calcification.

STAT3 signalling: A transcriptional pathway activated by cytokines and growth factors, mediating inflammatory responses and influencing matrix metabolism in chondrocytes.

References

1. Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration. Journal of Nanobiotechnology (2024).
2. Characterisation of a divergent progenitor cell sub-populations in human osteoarthritic cartilage: the role of telomere erosion and replicative senescence. Scientific Reports (2017).
3. Molecular characterization of mesenchymal stem cells in human osteoarthritis cartilage reveals contribution to the OA phenotype. Scientific Reports (2018).
4. Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage. Arthritis Research & Therapy (2013).
5. Intra-articular delivery of extracellular vesicles secreted by chondrogenic progenitor cells from MRL/MpJ superhealer mice enhances articular cartilage repair in a mouse injury model. Stem Cell Research & Therapy (2020).